Australian led trial shows mRNA vaccine lowers melanoma recurrence and death
An Australian-led phase three trial using a personalised mRNA vaccine combined with immunotherapy significantly reduced the risk of recurring melanoma and skin cancer deaths.
HEROIC BREAKING NEWS, written by our newsroom0 views
An Australian-led cancer trial using a personalised mRNA vaccine has significantly reduced the risk of recurring melanoma and skin cancer deaths, The West Australian reported on October 23, 2026. The world-first breakthrough combined the mRNA vaccine with a standard post-surgery immunotherapy drug. [1]
Principal investigator Professor Georgina Long described the results of the phase three trial as a major leap forward in cancer treatment, according to The West Australian. Long, who was named Australian of the Year in 2024 alongside the late Richard Scolyer, termed the milestone a landmark moment for medicine. [1]
The development represents a significant step in skin cancer care. As HEROIC BREAKING NEWS reported earlier, melanoma is a serious form of cancer, including rare types such as ocular melanoma. [1][4]
In short
- An Australian-led phase three trial combined a personalised mRNA vaccine with a post-surgery immunotherapy drug.
- The treatment significantly lowered the risk of melanoma recurrence and skin cancer-related death.
- Professor Georgina Long served as the principal investigator on the trial.
Sources
Every paragraph above points to the numbered items it rests on. Read the originals here.
- [1]Aussie-led trial of an mRNA cancer vaccine found to significantly reduce risk of recurring melanoma and deathThe West Australian, 4d ago (the report this story comes from)
Background
- [2]Australians on Wikipedia
- [3]Researchers identify drug target to reduce brain inflammation HEROIC BREAKING NEWS, 20d ago
- [4]Cancer survivor raises awareness using custom soccer themed prosthetic eye HEROIC BREAKING NEWS, 10d ago
Our newsroom writes these reports with the help of software, from the 4 sources listed and nothing else, and checks them against those sources. Facts can still be wrong or move on; the originals are the record. Spotted a mistake? Write to daniel@monsterkong.com.
Related from HEROIC BREAKING NEWS
Earlier reports of ours on the same people and subjects.
- Personalized mRNA Vaccine Cuts Melanoma Recurrence Risk in Phase 3 TrialMedical Breakthroughs, 1d ago
- Personalised mRNA melanoma vaccine expected to secure approval next yearMedical Breakthroughs, 3d ago
- Canadian Heart Disease Death Rate Drops Over Eighty Percent in Seventy-Five YearsMedical Breakthroughs, 7d ago
- Two Australian Patients Receive New Under Skin Prosthetic Arm ImplantHumanitarian Tech, 4d ago
- Local Drug Production Drops Prices for Life-Saving Medicines in BangladeshMedical Breakthroughs, 12d ago
More in Medical Breakthroughs
- Heart Foundation invests 14 point 5 million dollars in Australian research11m ago
- Mayo Clinic researchers uncover new strategies to target aging zombie cells1h ago
- Scientists discover anti inflammatory drugs may aid virus spread1h ago
- Artificial intelligence model detects early pancreatic cancer signs before conventional scans22h ago
- Biological computer created from living cells controls a robotic dog23h ago
- Scientists record magnetic skyrmion vortices to advance brain like computing1d ago
Get the day in one email
Reports like this one, the top news of the last 24 hours, every morning. Free, one email a day; readers can comment under every report.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.
Comments
Loading
Join the conversation
Comments are open to readers of our daily email: the top news of the last 24 hours, every morning, free. Sign up and the comment box opens.
Already on the list? Enter the same address and we will send a sign-in link.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.